56 related articles for article (PubMed ID: 1284750)
1. Detection of antibodies to HCV: comparison of a c100-3 EIA and the 2nd generation EIA.
Polywka S; Kaars-Wiele P; Schroeter E; Mandler J; Laufs R
Beitr Infusionsther; 1992; 30():42-5. PubMed ID: 1284750
[TBL] [Abstract][Full Text] [Related]
2. Abbott HCV EIA 2nd generation: a new screening assay.
Weise W; Bäcker U; Seidl S; Flacke H; Sondag D; Pirenne H; Schroeter E; Troonen H; Broeksma C; Heyermann H
Beitr Infusionsther; 1992; 30():34-7. PubMed ID: 1284729
[TBL] [Abstract][Full Text] [Related]
3. Detection of antibodies to hepatitis C virus in blood donors and their relationship to surrogate markers.
Hugo T; Wüst T; Beeser HP
Beitr Infusionsther; 1992; 30():49-52. PubMed ID: 1284765
[TBL] [Abstract][Full Text] [Related]
4. [Initial experiences with HCV detection and confirmation tests of the 3rd generation].
Knödler B; Kühnl P
Beitr Infusionsther; 1993; 31():10-5. PubMed ID: 7693234
[TBL] [Abstract][Full Text] [Related]
5. [HCV antibody test methods and patterns of antibody response].
Yahagi N; Kitsugi K
Rinsho Byori; 1991 Jun; 39(6):578-85. PubMed ID: 1652659
[TBL] [Abstract][Full Text] [Related]
6. Detection of antibodies to HCV in haemodialysis patients using two second generation ELISA tests.
Dentico P; Volpe A; Buongiorno R; Fiore G; Carbone M; Manno C; Pastore G; Schiraldi O
Ital J Gastroenterol; 1993 Jan; 25(1):19-22. PubMed ID: 7679012
[TBL] [Abstract][Full Text] [Related]
7. [Anti-HCV antibodies against the structural and nonstructural antigens of hepatitis C in people seropositive in the second generation test].
Juszczyk J; Flieger J; Migdalski P; Skalisz H
Przegl Epidemiol; 1992; 46(3):159-65. PubMed ID: 1284256
[TBL] [Abstract][Full Text] [Related]
8. Specificity and sensitivity of 3rd generation EIA for detection of HCV antibodies among intravenous drug-users.
Filice G; Patruno S; Campisi D; Chiesa A; Orsolini P; Debiaggi M; Bruno R; Tinelli M
New Microbiol; 1993 Jan; 16(1):35-42. PubMed ID: 7682283
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and incidence of hepatitis C virus (HCV) in hemodialysis patients: study of risk factors.
Dentico P; Buongiorno R; Volpe A; Carlone A; Carbone M; Manno C; Proscia F; Pastore G; Schiraldi O
Clin Nephrol; 1992 Jul; 38(1):49-52. PubMed ID: 1499169
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of antibody to hepatitis C virus in blood donors, high-risk groups and patients with liver diseases in Hungary. A multicentre study using ABBOTT EIA test and a comparison with an ORTHO ELISA test system.
Pár A; Kántor I; Barcsay E; Hollós I; Mezey I; Brojnás J; Takács M; Héjjas M; Illés M; Szontágh L
Acta Med Hung; 1991; 48(3-4):167-76. PubMed ID: 1726611
[TBL] [Abstract][Full Text] [Related]
11. [Decreasing the risk of post-transfusion non-A, non-B hepatitis by anti-HCV screening].
Holzberger G; Seidl S; Peschke B; Scheuermann EH; Schoeppe W
Beitr Infusionsther; 1992; 30():46-8. PubMed ID: 1284760
[TBL] [Abstract][Full Text] [Related]
12. Application of the Serodia-HCV particle agglutination for the detection of antibodies to hepatitis C virus.
Ooi BG; Sinniah M; Ismail S; Baharuddin R
Malays J Pathol; 1996 Dec; 18(2):89-93. PubMed ID: 10879228
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of antibodies to hepatitis C virus in patients on peritoneal dialysis--a multicenter study.
Gladziwa U; Schlipköter U; Lorbeer B; Cholmakow K; Roggendorf M; Sieberth HG
Clin Nephrol; 1993 Jul; 40(1):46-52. PubMed ID: 7689431
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity of second-generation enzyme immunoassay for detection of hepatitis C virus infection among oncology patients.
Macedo de Oliveira A; White KL; Beecham BD; Leschinsky DP; Foley BP; Dockter J; Giachetti C; Safranek TJ
J Clin Virol; 2006 Jan; 35(1):21-5. PubMed ID: 15921955
[TBL] [Abstract][Full Text] [Related]
15. [Prevention of post-transfusion non-A, non-B hepatitis by anti-HCV screening].
Holzberger G; Seidl S; Peschke B; Scheuermann EH; Schoeppe W
Infusionsther Transfusionsmed; 1992 Jun; 19(3):157-9. PubMed ID: 1379861
[TBL] [Abstract][Full Text] [Related]
16. [Prevalence of antibodies against hepatitis C virus in rheumatoid arthritis. Study using second-generation tests].
Marson P; Vicarioto M; Cavasin F; Volante D; De Silvestro G
Recenti Prog Med; 1991 Dec; 82(12):679-81. PubMed ID: 1667711
[TBL] [Abstract][Full Text] [Related]
17. [Prevalence of anti-HCV (C100-3) antibodies in 20.373 blood donors].
Zufferey C; Lavanchy D; Reiff M; Schneider P; Frei P; Pécoud A; Gonvers JJ
Schweiz Med Wochenschr; 1992 Oct; 122(41):1524-9. PubMed ID: 1411411
[TBL] [Abstract][Full Text] [Related]
18. Enzyme immunoassays for anti-hepatitis C virus antibodies improved specificity and analytical sensitivity by combination of three different recombinant viral proteins in second generation tests.
Prohaska W; Schroeter E; Kaars-Wiele P; Kleesiek K
Eur J Clin Chem Clin Biochem; 1992 Jul; 30(7):397-404. PubMed ID: 1381965
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus (HCV) infection in haemodialysed patients: HCV-RNA and anti-HCV antibodies (third-generation assays).
Couroucé AM; Bouchardeau F; Chauveau P; Le Marrec N; Girault A; Zins B; Naret C; Poignet JL
Nephrol Dial Transplant; 1995; 10(2):234-9. PubMed ID: 7538650
[TBL] [Abstract][Full Text] [Related]
20. [Infection of C type hepatitis virus in patients with alcoholism. Studied by serum HCV antibody of C100-3 and 2nd generation].
Ishii K; Sata M; Furudera S; Tanaka S; Kumashiro R; Tanikawa K; Abe H; Ishibashi M; Yokoyama T
Arukoru Kenkyuto Yakubutsu Ison; 1992 Apr; 27(2):180-8. PubMed ID: 1316746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
